Flint, Michigan Clinical Trials

1160.129.32047 Boehringer Ingelheim Investigational Site Updated

Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease

Aneurysm

Michigan Vascular Center

ANCHOR (Aneurysm Treatment Using the HeliFX Aortic Securement System Global Registry)

Atrial Fibrillation

GLORIA-AF Registry Program - Second and Third Phases

Breast Cancer

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Genesee Cancer & Blood Disease Treatment Center, PC

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Chronic Lymphocytic Leukemia

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Michigan State University / McLaren Regional Medical Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Diabetes Mellitus, Type 2

Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease

Call for Information (Investigational Site 0164) Updated

Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes

A Study of the Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-266 AM1)

Dyslipidemia

Cardiology Consultants of East Michigan

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk

Heart Failure

Longitudinal Surveillance Registry (LSR) of ACUITY Spiral

Heartburn

Pfizer Investigational Site

Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis and Maintenance of Healed Erosive Esophagitis and Relief of Heartburn in Adolescents

Kidney Transplantation

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Leukemia

Genesee Cancer & Blood Disease Treatment Center, PC

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Michigan State University / McLaren Regional Medical Center

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Lung Cancer

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Lupus Nephritis

ATLAS - Anti-Tweak in Lupus Nephritis Patients

Lymphoma

Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry

Metastatic Cancer

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Multiple Myeloma

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Connect® MM- The Multiple Myeloma Disease Registry

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Michigan State University/McLaren Regional Medical Center

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Connect® MM- The Multiple Myeloma Disease Registry

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Neoplasm Metastasis

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Genesys Hurley Cancer Institute Updated

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Neoplasms

S0820, Adenoma and Second Primary Prevention Trial

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Hurley Medical Center Updated

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

S0820, Adenoma and Second Primary Prevention Trial

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Nephritis

McLaren Regional Medical Center

ATLAS - Anti-Tweak in Lupus Nephritis Patients

Obesity

Efficacy of IV Acetaminophen in Acute Post-Operative Pain Control in Laparoscopic Roux-en-Y Gastric Bypass Surgery (LRYGBP) Patients

Pain

Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children

Prostate Cancer

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

1160.129.32047 Boehringer Ingelheim Investigational Site Updated

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Stroke

GLORIA-AF Registry Program - Second and Third Phases